Brandes AA - Search Results

1

Breast complaints and risk of breast cancer. Population-based study of 2,879 self-selected women and long-term follow-up.

Lumachi F, Ermani M, Brandes AA, Boccagni P, Polistina F, Basso SM, Favia G, D'Amico DF. Lumachi F, et al. Among authors: brandes aa. Biomed Pharmacother. 2002 Mar;56(2):88-92. doi: 10.1016/s0753-3322(01)00160-3. Biomed Pharmacother. 2002. PMID: 12000140

2

Prevalence of breast cancer in women with breast complaints. Retrospective analysis in a population of symptomatic patients.

Lumachi F, Ermani M, Brandes AA, Basso SM, Vastola F, Lonardi S, Boccagni P. Lumachi F, et al. Among authors: brandes aa. Anticancer Res. 2002 Nov-Dec;22(6B):3777-80. Anticancer Res. 2002. PMID: 12552991

3

Breast cancer risk in symptomatic women spontaneously undergoing clinical breast examination.

Lumachi F, Ermani M, Basso SM, Lonardi S, Tosoni A, Brandes AA. Lumachi F, et al. Among authors: brandes aa. Anticancer Res. 2003 Jul-Aug;23(4):3565-8. Anticancer Res. 2003. PMID: 12926108

4

Predictive value of different prognostic factors in breast cancer recurrences: multivariate analysis using a logistic regression model.

Lumachi F, Ermani M, Brandes AA, Basso S, Basso U, Boccagni P. Lumachi F, et al. Among authors: brandes aa. Anticancer Res. 2001 Nov-Dec;21(6A):4105-8. Anticancer Res. 2001. PMID: 11911301

5

Breast cancer risk in healthy and symptomatic women: results of a multivariate analysis. A case-control study.

Lumachi F, Ermani M, Brandes AA, Basso U, Paris M, Basso SM, Boccagni P. Lumachi F, et al. Among authors: brandes aa. Biomed Pharmacother. 2002 Oct;56(8):416-20. doi: 10.1016/s0753-3322(02)00252-4. Biomed Pharmacother. 2002. PMID: 12442915

6

Seroma prevention following axillary dissection in patients with breast cancer by using ultrasound scissors: a prospective clinical study.

Lumachi F, Brandes AA, Burelli P, Basso SM, Iacobone M, Ermani M. Lumachi F, et al. Among authors: brandes aa. Eur J Surg Oncol. 2004 Jun;30(5):526-30. doi: 10.1016/j.ejso.2004.03.003. Eur J Surg Oncol. 2004. PMID: 15135481 Clinical Trial.

7

Long-term follow-up study in breast cancer patients using serum tumor markers CEA and CA 15-3.

Lumachi F, Brandes AA, Boccagni P, Polistina F, Favia G, D'Amico DF. Lumachi F, et al. Among authors: brandes aa. Anticancer Res. 1999 Sep-Oct;19(5C):4485-9. Anticancer Res. 1999. PMID: 10650797

8

Sensitivity of serum tumor markers CEA and CA 15-3 in breast cancer recurrences and correlation with different prognostic factors.

Lumachi F, Brandes AA, Ermani M, Bruno G, Boccagni P. Lumachi F, et al. Among authors: brandes aa. Anticancer Res. 2000 Nov-Dec;20(6C):4751-5. Anticancer Res. 2000. PMID: 11205212

9

Relationship between tumor markers CEA and CA 15-3, TNM staging, estrogen receptor rate and MIB-1 index in patients with pT1-2 breast cancer.

Lumachi F, Basso SM, Brandes AA, Pagano D, Ermani M. Lumachi F, et al. Among authors: brandes aa. Anticancer Res. 2004 Sep-Oct;24(5B):3221-4. Anticancer Res. 2004. PMID: 15510614 Free article.

10

Sestamibi scintimammography in pT1 breast cancer: alternative or complementary to X-ray mammography?

Lumachi F, Ferretti G, Povolato M, Marzola MC, Zucchetta P, Geatti O, Bui F, Brandes AA. Lumachi F, et al. Among authors: brandes aa. Anticancer Res. 2001 May-Jun;21(3C):2201-5. Anticancer Res. 2001. PMID: 11501847 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

320 results

Search Page

Filters